The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states Tissue factor (TF) plays a pivotal role in the pathology of thrombosis in vivo. Phagocyte oxidants including H 2 O 2 and HOCl stimulate TF expression modestly (maximally 2-3 fold) in endothelial cells (15, 16) and monocytes. (17) Oxidants have also been implicated in activation of the NF-κB transcription factor (18) and the TF promoter has an NF-κB-like "TF-κB" binding site (19) . We hypothesized that EPO-derived oxidant, especially HOSCN, might also stimulate endothelial cell TF expression and thereby contribute to the pathogenesis of thrombosis in hypereosinophilic states. Using human umbilical vein endothelial
cells (HUVEC) as an in vitro model of EO-mediated endothelial and endocardial
only.
For personal use at PENN STATE UNIVERSITY on . bloodjournal.hematologylibrary.org From toxicity, we here show that HOSCN is a uniquely potent phagocyte oxidant activator of TF expression. HOSCN also stimulates the p65/p50 NF-κB pathway, raising the possibility that HOSCN also provokes expression of a variety of proinflammatory gene products relevant to EO-mediated tissue damage.
Materials and Reagents
Reagents. Lipopolysaccharide (Escherichia Coli 055:B5), NaSCN, NaBr, NaNO 2 , HOCl, andrographolide, lactoperoxidase, and protease inhibitor cocktail were from Sigma Aldrich. Ionophore A23187 was from EMD Biosciences. Hank's Balanced Salt HUVEC monolayers were exposed to oxidants using three different protocols: 1) by adding preformed reagent oxidants in a low (1%) serum system ( Figure 1A and 1B); 2) by an enzymatic reagent H 2 O 2 /eosinophil peroxidase system in serumfree buffer supplemented with one of three different potential EPO substrates ( Figure 1C) ; and 3) by adding preformed reagent oxidants in a high (10%) serum system (Figures 2 and 3 ).
Low-serum system. Reagent HOSCN was synthesized and quantitated as previously described using lactoperoxidase. (11, 12) Figure 2C ). HUVEC monolayers were exposed to either buffer control or 150 µM HOSCN at 37°C for 0, 2, 4 or 6 hours in the high serum system. Monolayers were washed with PBS+0.5 mM EDTA for 2 min, supernatants were removed, and the monolayers were harvested into single cell suspension with 0.5 mM EDTA/0.017% trypsin for 1 min, and washed once with ice-cold PBS + 10% (v/v) FBS, pH 7.4. HUVECs (6 x 10 5 ) were pelleted, washed with HBSA, and then incubated with 6 nM human factor VII a and 600 nM human factor X (both from Enzyme Research) and 10 mM CaCl 2 in HBSA at 37°C for 15 minutes. The supernatant was collected and assayed for TF activity using the X a -based clotting times as previously described. seconds, 72°C for 45 seconds; followed by a 7 minute extension at 72°C.
Assay of tissue factor activity of intact HUVEC (
Aliquots were analyzed by submarine electrophoresis by loading 10 µL PCR product on 1.5% agarose gels. Gels were stained using a 1:10,000 dilution of SYBR Green I (Molecular Probes) in 1X TBE buffer for 25 minutes at room temperature and imaged using ultraviolet transillumination. 
Immunofluorescence staining of p65 subunit of NF-B in HUVEC.
HUVECs were grown to confluence on glass cover slips, then exposed to M199 medium with 5% FBS (control), 10 µg/ml LPS, or 50 µM HOSCN 4 hours.
HUVECs were washed and fixed with 4% paraformaldehyde, and permeabilized with 0.1% Triton X-100. Specimens were then overlaid with 1 µg/ml rabbit antip65 polyclonal antibody and incubated at room temperature for 4 hours, then washed 3 times, exposed to FITC-conjugated goat anti-rabbit IgG, and analyzed by immunofluorescence microscopy (400×).
Kinase and transcription factor inhibitor studies. For kinase pathway inhibition studies, 10 µM U0126 and both 10 and 100 nM wortmannin were used as specific inhibitors of the ERK1/2 and PI3K kinase/Akt pathways, respectively. 10 μg/ml andrographolide was used as an inhibitor of the NF-κB pathway. (27) Monolayers of HUVECs in T-75 flasks were pretreated one hour with inhibitors, then exposed in 10% serum-containing medium with fresh inhibitors to either buffer control or 150 µM HOSCN. At various time points, flasks were either processed for TF factor activity assay or rinsed with HBSS without Ca 2+ or Mg 2+ then extracted with 300 µL of ice-cold lysis buffer (300 mM NaCl, 1.5 mM MgCl 2 , 200 µM EDTA, 0.1% Triton X-100, 25 mM HEPES, pH 7.6) with 5 mM dithiothreitol, 100 µM sodium orthovanadate, 20 mM β-glycerophosphate, 20
For personal use at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From µg/mL leupeptin hydrochloride, and 1 mM PMSF for 10 minutes. After vigorous scraping the lysate was collected and incubated on ice for 10 minutes further, then centrifuged 10 minutes at 13,000 × g. Total cell extracts and nuclear protein extracts were separated on 10% SDS-polyacrylamide gels and transferred to polyvinylidene difluoride membranes (Millipore). Membranes were blocked for 1 hour at room temperature with 5% nonfat dry milk in Tris-Buffered Saline (10 mM Tris, 150 mM NaCl, pH 7.5) with 0.01% Tween-20 (TBS/T). Primary antibodies were diluted in blocking buffer and incubated overnight at 4°C. After washing three times with TBS/T at room temperature, membranes were blocked for 1 hour at room temperature before the addition of alkaline phosphatase conjugated goat anti-rabbit or anti-mouse IgG antibodies (1:10,000 dilution) and incubating 1 hour at room temperature. After washing, membranes were exposed to 24 µL/cm 2 ECF Substrate (Amersham Pharmacia Biotech) for 10 minutes at room temperature and scanned on a Storm 860 Phosphoimager (Molecular Devices). We compared the relative capacity of each of these oxidants to induce TF activity in HUVEC monolayers ( Figure 1 ). We compared the ability of a purified eosinophil peroxidase system comprised of H 2 O 2 , eosinophil peroxidase, and each of its three preferred substrates --thiocyanate, bromide, or nitrite --to induce HUVEC TF expression ( Figure 1C ). To avoid the potential artifact of serum components scavenging the more reactive oxidants generated in the presence of bromide and nitrite, these experiments were performed in a serum-free system. Thirty minutes after adding increasing concentrations of H 2 O 2 to fuel the reactions, supernatant liquid was aspirated and the monolayers "rescued" by adding medium with 10% FBS before being assayed for TF activity after a further 4 hour incubation. Only in the presence of thiocyanate was significant induction of TF activity detectable.
Results

Comparative induction of
Collectively the experiments in the Figure 1 show that HOSCN is a uniquely potent phagocyte oxidant inducer of TF activity in endothelial cells. The potent oxidants HOCl and HOBr form less reactive but more stable chloro-and bromoamine adducts with primary amine moieties, including taurine, present in serum. These less reactive intermediates, unlike their parent oxidants, might induce TF expression by imposing intracellular oxidant stress, as does HOSCN. We therefore performed experiments in the presence of 10% FBS (Figure 2A) . Indeed, under these conditions some weak stimulatory activity by HOBr and HOCl at both 50 and 150 µM is seen, but enhancement by HOSCN is strikingly enhanced to as much as 30-fold over baseline. H 2 O 2 had no activity under these conditions. TF upregulation was confirmed by western blot analysis ( Figure 2B ). Because TF exists on cell membranes predominantly in an "encrypted" form that is inactive, we assayed the capacity of HOSCN to induce TF activity on intact cellular surfaces rather than whole cell lysates, where TF is maximally de-encrypted. (28) As shown in Figure 2C , when TF activity was measured in a two-stage assay in which oxidant-exposed monolayers were first presented with factors VII a and X, then supernatant X a activity subsequently quantitated in a clotting assay, HOSCN markedly stimulates TF activity on intact endothelial surfaces. In experiments not shown we have found that ≈ 15% of total lysate HUVEC TF activity is expressed on the intact cell surface (i.e., "deencrypted").
HOSCN upregulation of TF gene transcription: comparison with LPS.
To gauge the capacity of HOSCN to stimulate TF activity in endothelium we compared it with that of the potent in vivo agonist, LPS. As shown in Figure 3A, 150 µM HOSCN induction rivals that of 10 ng/ml of LPS and has a similar time
course, peaking at 8 hours and declining thereafter as well as exhibiting a lag time of 2-3 hours prior to induction is evident. To show that the activity of our HOSCN preparation was attributable to its oxidant character and not some contaminant, such as LPS, we examined the influence of TNB, which rapidly reduces or "scavanges" HOSCN, upon this activity. As shown in Figure 3B , TNB nearly totally reverses the capacity of our HOSCN preparation to induce TF activity without affecting LPS induction. To determine whether HOSCN, as does LPS, stimulates TF expression through transcriptional upregulation, we performed semi-quantitative RT-PCR analysis on RNA extracted from HUVEC monolayers at various time points after exposure to these agonists. As shown in Figure 3C , both HOSCN and LPS strikingly upregulate TF mRNA levels that is first detectable by 2 hours and peaks at 3-4 hours.
HOSCN influence upon AP-1, Egr-1, NF-κB and TF-κB transcription factor
activity. Because TF transcription is regulated by upstream binding sites for the AP-1, Egr-1, and TF κB-like transcription factors (17, 29-31), we assessed which, if any, of these factors was activated by HOSCN. First, because there is precedent for oxidant activation of the p65/p50 heterodimeric form of NF-κB (18) that is typically the most abundant isoform of the NF-κB family, we assayed the effect of LPS and HOSCN upon p65/p50 activation using an electrophoretic mobility shift assay (EMSA) analysis of HUVEC nuclear extracts prepared after 1 hour of exposure, reasoning that transcription factor activation would significantly preceed transcriptional activation. As shown in Figure 4A , both LPS and HOSCN --but not H 2 O 2 , HOCl, or HOBr --markedly increase expression of a p65/p50-
retardation band. That this band was compromised of both p65 and p50 was confirmed by "supershift assays" using specific polyclonal antibodies.
Specificity of the interaction was confirmed by the finding that excess unlabeled, but not excess mutant unlabeled probe, totally eliminated the p65/p50-specific band. However, human TF has a TF κB-like upstream sequence that is specific for the p65/c-Rel heterodimer, not p65/p50 (NF-κB). As shown in Figure 4B , both LPS and HOSCN activate p65/c-Rel though, as expected, this heterodimer is much less abundant than the p65/p50 isoform. p65-specific antibodies produced a supershift and c-Rel-specific antibodies diminished the intensity of the parent band without a convincing supershift. These results suggest that this complex is at least in part p65/c-Rel heterodimer.
Because activation of p65/p50 NF-κB is accompanied by translocation of subunits from the cytoplasm to the nucleus, we localized p65 in LPS-and HOSCN-exposed HUVEC monolayers by immunofluorescence microscopy.
Both LPS and HOSCN effected nuclear translocation of the p65 subunit ( Figure   4C ). Nuclear translocation of c-Rel, p65, and p50 was confirmed using Western blot assays of nuclear extracts ( Figure 4D ). Degradation of cytoplasmatic IκB-α was also confirmed. These results show HOSCN activates both p65/p50 (NF-κB) and p65/c-Rel (TF-κB) to an extent comparable to that of LPS.
EMSA analysis of AP-1 transcription factor activation ( Figure 5A virtue of its SH-specificity, capacity to impose intracellular oxidant stress (12) , and lack of reactivity with catalase might be an especially effective transcriptional inducer of TF activity. We therefore directly compared the capacity of the major phagocyte oxidants to influence TF expression in HUVEC.
We show that HOSCN is a uniquely potent (up to 100-fold) phagocyte oxidant inducer of HUVEC TF activity whose efficacy rivals that of the powerful (patho)physiologic TF inducer LPS ( Figure 3A) . TF induction was much more pronounced in the presence of complete media with 10% serum (Figure 3 B: HUVECs were exposed as decribed above to either buffer (control), 150 µM HOSCN or 10 ng/mL LPS, and in the presence or absence of 450 µM 5-thio-2-nitrobenzoic acid (TNB), then incubated 5 hours prior to assay of TF activity. C: HUVECs were exposed buffer, 150 µM HOSCN, or 10 ng/mL LPS as described above for the indicated time.
Total cellular RNA was extracted and analyzed by RT-PCR using either TF-(252 bp) or 18S rRNA-(324bp) specific primers. Gels were stained with SYBR Green I and imaged using ultraviolet transillumination.
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Five microgram aliquots of nuclear extracts were incubated with radiolabeled NF-κB consensus binding sequence oligonucleotide and separated on 5% non-denaturing polyacrylamide gels. The mobility of the shifted NF-κB consensus probe is shown by the arrow on the right; the slower migration of supershifted bands is shown in brackets. The lanes designated "consensus" show the effect of adding 10-fold excess unlabeled probe;
"mutant" the effect of adding 10-fold excess unlabeled mutant NF-κB consensus oligonucleotide; and "p65 Ab", "p50 Ab" and "c-Rel Ab" the effects of adding polyclonal antibodies to the designated proteins. B: As for A except HUVEC were incubated with the stimulant for 2h, the loading of 10 µg nuclear extract protein/lane, and use of a radiolabeled oligonucleotide probe comprising the authentic TF TF-κB-like sequence. C:
Immunofluorescent microscopy localization of p65 in HUVEC monolayers exposed to 10 µg/mL LPS or 50 µM HOSCN in M199 medium with 5% FBS for 4 hours, fixed with 4% paraformaldehyde, and permeabilized with 0.1% Triton X-100. p65 was visualized using a rabbit anti-p65 polyclonal primary antibody and a FITC-conjugated goat antirabbit IgG secondary antibody by immunofluorescence microscopy (400×). D: Western blot analysis of the nuclear extracts used for 1 h (left panel) and 2 h(right panel) using polyclonal antibodies specific for the designated proteins with SP1 as a loading control.
For IκB-α only, cytosolic rather than nuclear extracts were analyzed with actin as a loading control.
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